Related Experiment Videos
Economic or medical criteria, or both, in policy decisions about medicines?
Journal of Health Economics
|November 7, 1983
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Graphical analysis of multivariate pain data in analgesic trials.
Controlled clinical trials·1986
The development of self-originated new drugs by Swiss pharmaceutical firms, 1960-1980.
Regulatory toxicology and pharmacology : RTP·1984
Drug discontinuations in the United Kingdom and the United States, 1964 to 1983: issues of safety.
Clinical pharmacology and therapeutics·1984
New drug development during and after a period of regulatory change: clinical research activity of major United States pharmaceutical firms, 1958 to 1979.
Clinical pharmacology and therapeutics·1983
New drug development by United States pharmaceutical firms with analyses of trends in the acquisition and origin of drug candidates, 1963-1979.
Clinical pharmacology and therapeutics·1982
Analgesic efficacy of parenteral metkephamid acetate in treatment of postoperative pain.
Lancet (London, England)·1982
Beyond targeting women: Intrahousehold contexts and the effectiveness of food vouchers.
Journal of health economics·2026
The rise and fall (and rise) of the Affordable Care Act: Varying impacts on coverage over time and place.
Journal of health economics·2026
In sickness and in health insurance: Gender in household benefit plan choice.
Journal of health economics·2026
The adverse effects of weight reports in schools.
Journal of health economics·2026
Risk, time, and diet quality: Evidence from a general population survey.
Journal of health economics·2026
Labor unions and deaths of despair: Evidence from right-to-work laws.
Journal of health economics·2026
Comparative drug survival of biologic classes in psoriasis: a Japanese single-centre cohort study.
European journal of dermatology : EJD·2026
Biologic treatments for palmoplantar psoriasis and palmoplantar pustulosis: a systematic review and network meta-analysis.
European journal of dermatology : EJD·2026
Safety and Efficacy of Doravirine/Islatravir (100 mg/0.25 mg) Once Daily after Islatravir Dose Reduction from 0.75 mg: Week 96 Results from an Open-Label Phase 3 Study in Adults with HIV-1.
Journal of acquired immune deficiency syndromes (1999)·2026
Target engagement and efficacy in disease-modifying trials of synuclein-related disorders.
Brain : a journal of neurology·2026